Publications

Results 1-8 of 8 (Search time: 0.002 seconds).

PreviewIssue DateTitleAuthor(s)
1May-2017A randomised double-blind trial of phenylephrine and metaraminol infusions for prevention of hypotension during spinal and combined-spinal epidural anaesthesia for elective caesarean section.McDonnell, NJ ; Paech, MJ ; Muchatuta, NA; Hillyard, S ; Nathan, EA
2May-2016Severe Nausea and Vomiting in the Evaluation of Nitrous Oxide in the Gas Mixture for Anesthesia II TrialMyles PS ; Chan MT; Kasza J; Paech MJ ; Leslie K ; Peyton PJ; Sessler DI; Haller G; Beattie WS; Osborne C; Sneyd JR; Forbes A
318-Oct-2014The safety of addition of nitrous oxide to general anaesthesia in at-risk patients having major non-cardiac surgery (ENIGMA-II): a randomised, single-blind trial.Myles, PS ; Leslie, K ; Chan, MTV ; Forbes, A; Peyton, PJ ; Paech, MJ ; Beattie, S; Sessler, DI; Devereaux, PJ; Silbert, BS ; Schricker, T; Wallace, S; ANZCA Trials Group for the ENIGMA-II investigators
4Aug-2011A cost-benefit analysis of the ENIGMA trialGraham, AM; Myles, PS ; Leslie, K ; Chan, MT; Paech, MJ ; Peyton, PJ ; El Dawlatly, AA
5Feb-2011Nitrous oxide and long-term morbidity and mortality in the ENIGMA trial.Leslie, K ; Myles, PS ; Chan, MTV ; Forbes, A; Paech, MJ ; Peyton, PJ ; Silbert, BS ; Williamson, E
6Oct-2008Difficult and failed intubation in obstetric anaesthesia: an observational study of airway management and complications associated with general anaesthesia for caesarean section.McDonnell, NJ ; Paech, MJ ; Clavisi, OM; Scott, KL; ANZCA Clinical Trials Network 
7Oct-2008A prospective study of awareness and recall associated with general anaesthesia for caesarean section.Paech, MJ ; Scott, KL; Clavisi, O; Chua, S; McDonnell, NJ ; ANZCA Clinical Trials Network 
8-Implication of Major Adverse Postoperative Events and Myocardial Injury on Disability and Survival: A Planned Subanalysis of the ENIGMA-II Trial.Beattie, WS; Wijeysundera, DN; Chan, MTV ; Peyton, PJ ; Leslie, K ; Paech, MJ ; Sessler, DI; Wallace, S; Myles, PS ; Galagher, W; Farrington, C; Ditoro, A; Baulch, S; Sidiropoulos, S; Bulach, R; Bryant, D; O'Loughlin, E ; Mitteregger, V; Bolsin, S; Osborne, C; McRae, R; Backstrom, M; Cotter, R; March, S; Silbert, B; Said, S; Halliwell, R; Cope, J; Fahlbusch, D; Crump, D; Thompson, G; Jefferies, A; Reeves, M; Buckley, N; Tidy, T; Schricker, T; Lattermann, R; Iannuzzi, D; Carroll, J; Jacka, M; Bryden, C; Badner, N; Tsang, MWY; Cheng, BCP; Fong, ACM; Chu, LCY ; Koo, EGY; Mohd, N; Ming, LE; Campbell, D; McAllister, D; Walker, S; Olliff, S; Kennedy, R; Eldawlatly, A; Alzahrani, T; Chua, N; Sneyd, R; McMillan, H; Parkinson, I; Brennan, A; Balaji, P; Nightingale, J; Kunst, G; Dickinson, M; Subramaniam, B; Banner-Godspeed, V; Liu, J; Kurz, A; Hesler, B; Fu, AY; Egan, C; Fiffick, AN; Hutcherson MT; Turan, A; Naylor, A; Obal, D; Cooke, E; ANZCA Clinical Trials Network for the ENIGMA-II Investigators. Abstract